Author: Hossein-khannazer, Nikoo; Shokoohian, Bahare; Shpichka, Anastasia; Aghdaei, Hamid Asadzadeh; Timashev, Peter; Vosough, Massoud
Title: Novel therapeutic approaches for treatment of COVID-19 Cord-id: wukbehck Document date: 2020_6_3
ID: wukbehck
Snippet: To date, there is no licensed treatment or approved vaccine to combat the coronavirus disease of 2019 (COVID-19), and the number of new cases and mortality multiplies every day. Therefore, it is essential to develop an effective treatment strategy to control the virus spread and prevent the disease. Here, we summarized the therapeutic approaches that are used to treat this infection. Although it seems that antiviral drugs are effective in improving clinical manifestation, there is no definite tr
Document: To date, there is no licensed treatment or approved vaccine to combat the coronavirus disease of 2019 (COVID-19), and the number of new cases and mortality multiplies every day. Therefore, it is essential to develop an effective treatment strategy to control the virus spread and prevent the disease. Here, we summarized the therapeutic approaches that are used to treat this infection. Although it seems that antiviral drugs are effective in improving clinical manifestation, there is no definite treatment protocol. Lymphocytopenia, excessive inflammation, and cytokine storm followed by acute respiratory distress syndrome are still unsolved issues causing the severity of this disease. Therefore, immune response modulation and inflammation management can be considered as an essential step. There is no doubt that more studies are required to clarify immunopathogenesis and immune response; however, new therapeutic approaches including mesenchymal stromal cell and immune cell therapy showed inspiring results.
Search related documents:
Co phrase search for related documents- aberrant host immune response and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9
- aberrant host immune response and acute respiratory syndrome coronavirus: 1, 2
- actively study and acute respiratory: 1
- actively study and adoptive transfer: 1
- acute ali lung injury and adoptive transfer: 1, 2
- acute ards respiratory distress syndrome and ade antibody dependent enhancement: 1, 2
- acute ards respiratory distress syndrome and adoptive transfer: 1, 2
- acute ards respiratory distress syndrome and long lasting: 1, 2, 3
- acute respiratory and ade antibody dependent enhancement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and adoptive transfer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute respiratory and long lasting: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and long lesion: 1
- acute respiratory syndrome coronavirus and ade antibody dependent enhancement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome coronavirus and adoptive transfer: 1, 2, 3, 4, 5, 6, 7
- acute respiratory syndrome coronavirus and long lasting: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome coronavirus and long lesion: 1
- ade antibody dependent enhancement and long lasting: 1
Co phrase search for related documents, hyperlinks ordered by date